Peripheral-type benzodiazepine receptors in diagnostic subtypes of schizophrenic patients

Psychiatry Research

Volumn 81, Issue 3, 1998, Pages 363-369

  Wodarz, Norbert ^a   Rothenhöfer, Christiane ^b   Fischer, Roswitha ^b   Stöber, Gerald ^b   Kiehl, Benno ^c   Jungkunz, Gerd ^c   Riederer, Peter ^b   Klein, Helmfried E ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c District Hospital Lohr   (Germany)

Author keywords

Catatonic schizophrenia; Paranoid schizophrenia; Residual schizophrenia

Indexed keywords

BENZODIAZEPINE RECEPTOR; RECEPTOR SUBTYPE;

ADULT; ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NEGATIVE SYNDROME; NERVE CELL MEMBRANE; PRIORITY JOURNAL; SCHIZOPHRENIA; STEROIDOGENESIS;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; GRANULOCYTES; HUMANS; ISOQUINOLINES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, GABA-A; REFERENCE VALUES; SCHIZOPHRENIA;

EID: 0032517881     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(98)00098-5     Document Type: Article

References (35)

1. American Psychiatric Association; Committee on Nomenclature and Statistics, 1994. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, Washington DC.
2. Braestrup C., Albrechtsen R., Squires R.F. High densities of benzodiazepine receptors in human cortical areas. Nature. 269:1977;702-704.
3. Camins A., Diez Fernandez C., Camarasa J., Escubedo E. Cell surface expression of heat shock proteins in dog neutrophils induced by mitochondrial benzodiazepine receptor ligands. Immunopharmacology. 29:1995;159-166.
4. Canat X., Carayon P., Bouaboula M., Cahard D., Shire D., Roque C., Le-Fur G., Casellas P. Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells. Life Sciences. 52:1993;107-118.
5. Crimlisk H.L. The little imitator - porphyria: a neuropsychiatric disorder. Journal of Neurology, Neurosurgery and Psychiatry. 62:1997;319-328.
6. Ferrarese C., Appollonio I., Frigo M., Perego M., Piolti R., Trabucchi M., Frattola L. Decreased density of benzodiazepine receptors in lymphocytes of anxious patients: reversal after chronic diazepam treatment. Acta Psychiatrica Scandinavica. 82:1990;169-173.
7. Ferrero P., Rocca P., Montalenti E., Benna P., Milani A., Ravizza L., Bergamasco B. Peripheral-type benzodiazepine receptors on human blood mononuclear cells are not regulated by ovarian steroids. Psychoneuroendocrinology. 19:1994;65-78.
8. Gavish M., Weizman A., Karp L., Tyano S., Tanne Z. Decreased peripheral benzodiazepine binding sites in platelets of neuroleptic-treated schizophrenics. European Journal of Pharmacology. 121:1986;275-279.
9. Gavish M., Katz Y., Bar-Ami S., Weizman R. Biochemical, physiological, and pathological aspects of the peripheral benzodiazepine receptor. Journal of Neurochemistry. 58:1992;1589-1601.
10. Gavish M., Laor N., Bidder M., Fisher D., Fonia O., Muller U., Reiss A., Wolmer L., Karp L., Weizman R. Altered platelet peripheral-type benzodiazepine receptor in posttraumatic stress disorder. Neuropsychopharmacology. 14:1996;181-186.
11. Itzhak Y., Norenberg M.D. Regulation of peripheral-type benzodiazepine receptors in cultured astrocytes by monoamine and amino acid neurotransmitters. Brain Research. 660:1994;346-348.
12. Joels M. Steroid hormones and excitability in the mammalian brain. Frontiers in Neuroendocrinology. 18:1997;2-48.
13. Kiuchi Y., Kobayashi T., Takeuchi J., Shimizu H., Ogata H., Toru M. Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics. European Archives of Psychiatry and Neurological Science. 239:1989;71-78.
14. Kozikowski A.P., Ma D., Brewer J., Sun S., Costa E., Romeo E., Guidotti A. Chemistry, binding affinities, and behavioral properties of a new class of 'antineophobic' mitochondrial DBI receptor complex (mDRC) ligands. Journal of Medical Chemistry. 36:1993;2908-2920.
15. Langer S.Z., Arbilla S. Limitations of the benzodiazepine receptor nomenclature: a proposal for a pharmacological classification as omega receptor subtypes. Fundamental and Clinical Pharmacology. 2:1988;159-170.
16. Lin D., Chang Y.J., Strauss J.F., Miller W.L. The human peripheral benzodiazepine receptor gene: cloning and characterization of alternative splicing in normal tissues and in a patient with congenital lipoid adrenal hyperplasia. Genomics. 18:1993;643-650.
17. Marazziti D., Pancioli-Guadagnucci M.L., Rotondo A., Giannaccini G., Martini C., Lucacchini A., Cassano G.B. Age-related changes in peripheral benzodiazepine receptors of human platelets. Journal of Psychiatry and Neuroscience. 19:1994;136-139.
18. Marazziti D., Rotondo A., Martini C., Giannaccini G., Lucacchini A., Pancioli-Guadagnucci M.L., Diamond B.I., Borison R., Cassano G.B. Changes in peripheral benzodiazepine receptors in patients with panic disorder and obsessive-compulsive disorder. Neuropsychobiology. 29:1994;8-11.
19. Mathis C., Vogel E., Cagniard B., Criscuolo F., Ungerer A. The neurosteroid pregnenolone sulfate blocks deficits induced by a competitive NMDA antagonist in active avoidance and lever-press learning tasks in mice. Neuropharmacology. 35:1996;1057-1064.
20. Mohler H., Okada T. Benzodiazepine receptor: demonstration in the central nervous system. Science. 198:1977;849-851.
21. Munson P.J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Analytical Biochemistry. 107:1980;220-239.
22. Parola A.L., Yamamura H.I., Laird H.E. Peripheral-type benzodiazepine receptors. Life Sciences. 52:1993;1329-1342.
23. Reddy D.S., Kulkarni S.K. Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the anti-stress activity of neurosteroids in mice. Psychopharmacology. 128:1996;280-292.
24. Reynolds G.P., Stroud D. Hippocampal benzodiazepine receptors in schizophrenia. Journal of Neural Transmission - General Secton. 93:1993;151-155.
25. Roberts E. Prospects for research on schizophrenia. An hypothesis suggesting that there is a defect in the GABA system in schizophrenia. Neurosciences Research Program, Bulletin. 10:1972;468-482.
26. Rocca P., Ferrero P., Gualerzi A., Zanalda E., Maina G., Bergamasco B., Ravizza L. Peripheral-type benzodiazepine receptors in anxiety disorders. Acta Psychiatrica Scandinavica. 84:1991;537-544.
27. Rocca P., Beoni A.M., Eva C., Ferrero P., Zanalda E., Ravizza L. Peripheral benzodiazepine receptor messenger RNA is decreased in lymphocytes of generalized anxiety disorder patients. Biological Psychiatry. 43:1998;767-773.
28. Tanne Z., Weizman R., Karp L., Katz Y., Tyano S., Gavish M. Lack of effect of 28 days of neuroleptic treatment on platelet benzodiazepine binding sites in schizophrenics. Neuropsychobiology. 17:1987;121-123.
29. Weizman R., Tanne Z., Karp L., Tyano S., Gavish M. Peripheral-type benzodiazepine-binding sites in platelets of schizophrenics with and without tardive dyskinesia. Life Sciences. 39:1986;549-555.
30. Weizman R., Tanne Z., Granek M., Karp L., Golomb M., Tyano S., Gavish M. Peripheral benzodiazepine binding sites on platelet membranes are increased during diazepam treatment of anxious patients. European Journal of Pharmacology. 138:1987;289-292.
31. Weizman R., Hermesh H., Karp L., Dar D.E., Munitz H., Gavish M. The platelet benzodiazepine receptor is unaltered in obsessive-compulsive disorder. Clinical Neuropharmacology. 16:1993;211-215.
32. Weizman R., Gavish M. Molecular cellular and behavioral aspects of peripheral-type benzodiazepine receptors. Clinical Neuropharmacology. 16:1993;401-417.
33. WHO, 1991. Klinisch-diagnostische Leitlinien. In: Dilling, H., Mombur, W., Schmidt, M.H. (Eds.), Internationale Klassifikation psychischer Störungen ICD-10.
34. 3H]-spiroperidol binding to human peripheral mononuclear cells: methodological aspects. Biological Psychiatry. 31:1992;291-303.
35. 3H]-spiroperidol binding to peripheral mononuclear cells in schizophrenic and healthy subjects. Biological Psychiatry. 33:1993;727-733.